GENE ONLINE|News &
Opinion
Blog

Stock
Ascentage Pharma
China’s Ascentage Snatches First Biotech IPO Price of 2025, Raking in $126M
2025-01-24
Getting a Full View: 5 Breakthrough Biotech Stocks to Watch in 2025
2025-01-06
In-Depth market insightsbiotech industry
Five Biotech Stocks Soar: Eyes on Halozyme, United Therapeutics, Harmony, Ligand, and ADMA
2024-09-19
Ranking & Reports market insightsViking Therapeutics
Viking Therapeutics Ready to Make Billions as a Strong Contender in the GLP-1 Weight Loss Space
2024-08-29
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
READ MORE
EVENT
2026-03-23
DCAT Week
New York, USA
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
2026-03-23
29th European Biotechnology Congress (Biotech R&D)
Rome, Italy
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
2026-04-29
BIO Korea 2026 (R&D & Collaborations)
Seoul, South Korea
SEE MORE
Scroll to Top